News

Engagement of Altimmune at Notable Investor Conferences Ahead

Engagement of Altimmune at Notable Investor Conferences Ahead

Altimmune to Present at Significant Investor Conferences

GAITHERSBURG, Md. — Altimmune, Inc. (Nasdaq: ALT), a pioneering biopharmaceutical company, is dedicated to developing innovative peptide-based therapeutics targeting liver and cardiometabolic disorders. The Company is gearing up for participation in two noteworthy investor conferences, where members of its management team will engage with attendees and conduct one-on-one meetings.

Upcoming Conference Details

Altimmune's presence at these events marks an opportunity for investors to gain insights into the company's advancements and strategic vision. The conferences include:

H.C. Wainwright 3rd Annual BioConnect Investor Conference

Scheduled for May 20, this conference located in New York will feature a fireside chat at 10:00 a.m. Eastern Time, providing a platform for Altimmune to share its progress and future aspirations.

Jefferies Global Healthcare Conference

On June 4, Altimmune will participate in another significant event in New York, with a fireside chat set for 9:55 a.m. Eastern Time. This engagement will further highlight the Company’s commitment to investors and stakeholders in the healthcare community.

Accessing the Presentations

The sessions will be streamed live, allowing interested parties to follow along and engage with the presented content. For those wishing to view the presentations, the webcast can be accessed via the Events section of the Altimmune website, ensuring everyone can stay informed about the latest developments in the company's research and initiatives.

About Altimmune and Its Innovations

Altimmune is at the forefront of developing forward-thinking biopharmaceutical solutions. The Company’s leading program, pemvidutide, is gaining notoriety as a dual GLP-1/glucagon receptor agonist and is instrumental in treating conditions such as metabolic-associated steatotic liver disease (MASH), obesity, Alcohol Use Disorder (AUD), and Alcohol Liver Disease (ALD). These therapeutic innovations highlight Altimmune's pivotal role in combating significant health challenges.

Discover more about the groundbreaking work at Altimmune by visiting their official website or social media channels.

Company Contacts

If you have inquiries regarding company updates or investor relations, feel free to reach out to:

Company Contact:

Greg Weaver
Chief Financial Officer
Phone: 240-654-1450
Email: ir@altimmune.com

Investor Contact:

Lee Roth
Burns McClellan
Phone: 646-382-3403
Email: lroth@burnsmc.com

Media Contact:

Jake Robison
Inizio Evoke Comms
Phone: 619-849-5383
Email: Jake.robison@inizioevoke.com

Frequently Asked Questions

What is the main focus of Altimmune?

Altimmune focuses on developing innovative peptide-based therapeutics aimed at treating liver and cardiometabolic diseases.

When are the upcoming conferences Altimmune will attend?

Altimmune will participate in the H.C. Wainwright BioConnect Conference on May 20, followed by the Jefferies Global Healthcare Conference on June 4.

How can I access Altimmune’s presentations during the conferences?

The presentations will be available via live stream on Altimmune's website under the Events section.

What is pemvidutide?

Pemvidutide is Altimmune’s lead therapeutic program, designed as a dual GLP-1/glucagon receptor agonist that targets conditions like obesity and liver diseases.

How can I get in touch with Altimmune for investor queries?

Investors can contact Greg Weaver, the CFO, at 240-654-1450 or via email at ir@altimmune.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ON1 Photo RAW 2027: New AI Tools, Better Processing

Updated Category News Views 0

Aiming for the Photography Crown ON1 isn't just tinkering on the fringes with their new Photo RAW 2027 release—they're diving headfirst into the deep end, aiming to outdo giants in the RAW processing world. I've seen my share of software updates that don't move the needle, but this one's packed to the gills with updates that photographers have been clamoring for. What's...

Continue Reading
Clarivate Integrates Trademark Data with Microsoft AI

Updated Category News Views 8

You know, the market's all abuzz with AI this, AI that. But today, we're getting a glimpse at something that isn't just hyped-up vaporware; it's actually useful. Clarivate Plc (NYSE:CLVT), which has carved a niche in transformative intelligence, is teaming up with Microsoft to slide their CompuMark trademark data into Microsoft Copilot via something they call IPOne. It's...

Continue Reading
New Leadership Fuels Expansion of Black Optix Tint

Updated Category News Views 53

Shifting Gears with New Leadership Black Optix Tint isn't just revamping its car-styling game; it's refueling the entire brand with the appointment of Jeff Stark as its new brand president. This guy's entry into the picture is like putting nitro in the tank of a franchise that's already got some serious road miles behind it. With over 15 years under his belt in the...

Continue Reading
Cleafy's Cyber-Fraud Edge in SPARK Matrix™ 2026

Updated Category News Views 58

What's Cookin'? Cleafy Leads in Fraud Management Lineup Eying the world through a prism of calculated risk and opportunity, Cleafy has emerged a big dog in the latest QKS Group SPARK Matrix™ for Enterprise Fraud Management, 2026. The spotlight's on their cutting-edge knack for dodging cyber fraud's punches, a distinction that hints at a deeper market shift for those who...

Continue Reading
3W Auto-life Unveils New Products at SEMA Show 2026

Updated Category News Views 15

Revving Up Interest at SEMA with 3W Auto-life If there's ever a mecca for car accessories in the automotive world, the SEMA Show in Las Vegas is it. Right there in the West Hall, Booth #54169, 3W Auto-life is flaunting their 2026 lineup, marking a decade of transformation in vehicle interior protection. From upgraded floor mats for the Tesla Model Y Juniper and the Toyota...

Continue Reading
AAR's Big Bet on Notes Amid MRO Holdings Acquisition

Updated Category News Views 9

AAR's $1.9 Billion Move in the Aviation Arena The aviation aftermarket giant AAR isn't just dipping its toes into the bond market—it's diving in headfirst with a hefty $1.9 billion in senior notes. These notes, spread across two separate issues due in 2031 and 2034, are part of a broader strategy to finance the takeover of MRO Holdings. It's a bold move, but in the...

Continue Reading
Ceva and Mobilint's New REGULUS: A Game Changer?

Updated Category News Views 71

A Big Leap for Physical AI Can't pretend I saw this coming—Ceva's making waves with Mobilint's new REGULUS edge AI SoC, aiming to flip the script on how we think about physical AI devices. This combo of Ceva's NeuPro NPU and SensPro AI DSP is more than just tech talk; it's a gutsy move that shows us edge devices might be the hunting ground for AI innovation. Sensors and...

Continue Reading
ENGWE Unleashes Massive Black Friday E-Bike Discounts

Updated Category News Views 93

ENGWE Powers Up the 2026 Black Friday Storm If you’ve ever been on the hunt for a reliable e-bike, ENGWE is making a racket that’ll be impossible to ignore this Black Friday. Starting November 2nd and running up to December 3rd, they’re throwing down the gauntlet with some jaw-dropping deals across their line-up. Now, why should you care? For starters, they’ve...

Continue Reading
Curaleaf Takes Stake in NJ's Boone Town Dispensary

Updated Category News Views 109

Curaleaf's Bold Move in the Garden State Curaleaf Holdings, Inc. is doubling down on its cannabis bet in New Jersey. The acquisition of an equity stake in Boone Town Provisions, located at 677 Myrtle Ave., Boonton, NJ, boosts Curaleaf’s dispensary count to four in the state. The company's not just wandering on the map; it's pinpointing high-performing locations to...

Continue Reading
November Oil Outlook: OPEC+ Steady, Key Earnings Ahead

Updated Category News Views 57

Oil's November Gambit: OPEC+ and U.S. Dynamics November's here, and boy, it's shaping up to be a wild one for the oil market. OPEC+ decided to stick with their oil production targets for December, leaving the supply faucets unchanged. This group, including big players like Saudi Arabia and Russia, met virtually and chose to hit the brakes on any changes just yet. With the...

Continue Reading

Top 5 Most Recently Viewed Articles

Alpine Banks of Colorado Secures Shareholder Approval for Stock Split

Updated Category News Views 282

Shareholder Approval for Stock Split and Articles Amendment Alpine Banks of Colorado (OTCQX: ALPIB) recently reached a significant milestone as it secured shareholder approval for critical adjustments to its corporate structure. These changes, voted on during the annual meeting, include the amendment and restatement of the Articles of Incorporation, which set the...

Continue Reading
John Drosos Joins Blue Ridge Partners as Managing Director

Updated Category News Views 65

Blue Ridge Partners Welcomes John Drosos as Managing Director Global management consultancy adds highly experienced and talented Managing Director to its growing leadership team. Expertise and Experience Blue Ridge Partners is excited to announce that John Drosos has joined the firm as Managing Director, bringing with him over 25 years of expertise in consulting, private...

Continue Reading
America's Economic Boom and the Path to a Better Future

Updated Category News Views 461

America's Economic Boom: An Update In a remarkable turn of events, America's economy is showcasing impressive growth and significant progress. Under the leadership of President Trump, the nation has become a focal point of economic success. With a clear emphasis on addressing fundamental issues, the current administration is working tirelessly to rectify longstanding...

Continue Reading
Effortless Home Selling: Explore a New 3-Step Process in Texas

Updated Category News Views 108

Simplified Home Selling in Texas Company That Buys Houses proudly introduces a revolutionary 3-step approach for homeowners looking to sell their property efficiently in Texas. This method is designed to provide an uncomplicated experience for those wanting to sell their homes in 'as-is' condition without the usual hassles of traditional real estate transactions....

Continue Reading
Projected Growth of Air Purifying Escape Respirators

Updated Category News Views 153

The Promising Future of the Air Purifying Escape Respirator Market The global Air Purifying Escape Respirator market is undergoing a transformation, with exciting growth projected over the next decade. Currently valued at approximately US$ 7.4 billion, it is anticipated to reach around US$ 12.9 billion, exhibiting a steady compound annual growth rate (CAGR) of 5.2%...

Continue Reading